Table 2.
18F-PSMA-1007 PET/CT parameters for different PSA, Gleason score, and metastasis status subgroups.
| Categorical variable | PSA <20 ng/mL n = 82 | PSA ≥20 ng/mL n = 79 | Sig | GS <8 n = 68 | GS ≥8 n = 93 | Sig | Non-metastasis n = 86 | Metastasis n = 75 | Sig |
|---|---|---|---|---|---|---|---|---|---|
| SUVmin Mean ± SD (range) |
5.80 ± 5.47 1.36-28.87 |
8.88 ± 6.43 0.60-37.95 |
P = 0.001 | 5.69 ± 4.39 1.41-15.18 |
8.50 ± 6.94 0.6-37.95 |
P = 0.002 | 8.15 ± 6.83 1.41-37.95 |
6.35 ± 5.12 0.60-24.50 |
P = 0.058 |
| SUVmax Mean ± SD (range) |
20.31 ± 16.18 3.89-76.86 |
28.88 ± 7.76 3.60-101.89 |
P = 0.002 | 20.63 ± 12.97 3.60-57.77 |
27.35 ± 19.71 3.89-101.89 |
P = 0.01 | 26.23 ± 19.18 4.38-101.89 |
22.54 ± 15.15 3.60-62.95 |
P = 0.181 |
| SUVmean Mean ± SD (range) |
9.31 ± 8.10 1.84–41.55 |
13.85 ± 9.61 1.80–57.85 |
P = 0.001 | 9.18 ± 6.28 1.80–31.43 |
13.26 ± 10.45 1.84-57.85 |
P = 0.002 | 12.71 ± 10.09 2.23-57.85 |
10.19 ± 7.75 1.80-37.48 |
P = 0.075 |